These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 18317969
1. The use of dynamic positron emission tomography imaging for evaluating the carcinogenic progression of intestinal metaplasia to esophageal adenocarcinoma. Li Y, Woodall C, Wo JM, Zheng H, Ng CK, Ray MB, Martin RC. Cancer Invest; 2008; 26(3):278-85. PubMed ID: 18317969 [Abstract] [Full Text] [Related]
2. Alterations in manganese superoxide dismutase expression in the progression from reflux esophagitis to esophageal adenocarcinoma. Li Y, Wo JM, Su RR, Ray MB, Martin RC. Ann Surg Oncol; 2007 Jul; 14(7):2045-55. PubMed ID: 17473952 [Abstract] [Full Text] [Related]
3. Chemoprevention of carcinogenic progression to esophageal adenocarcinoma by the manganese superoxide dismutase supplementation. Martin RC, Liu Q, Wo JM, Ray MB, Li Y. Clin Cancer Res; 2007 Sep 01; 13(17):5176-82. PubMed ID: 17785574 [Abstract] [Full Text] [Related]
4. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus. Buskens CJ, Hulscher JB, van Gulik TM, Ten Kate FJ, van Lanschot JJ. J Surg Res; 2006 Oct 01; 135(2):337-44. PubMed ID: 16926029 [Abstract] [Full Text] [Related]
5. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study. Sikkema M, Kerkhof M, Steyerberg EW, Kusters JG, van Strien PM, Looman CW, van Dekken H, Siersema PD, Kuipers EJ. Am J Gastroenterol; 2009 Nov 01; 104(11):2673-80. PubMed ID: 19638963 [Abstract] [Full Text] [Related]
6. The molecular biology of esophageal adenocarcinoma. Koppert LB, Wijnhoven BP, van Dekken H, Tilanus HW, Dinjens WN. J Surg Oncol; 2005 Dec 01; 92(3):169-90. PubMed ID: 16299787 [Abstract] [Full Text] [Related]
7. Histology of metaplasia and dysplasia in Barrett's esophagus. Yerian L. Surg Oncol Clin N Am; 2009 Jul 01; 18(3):411-22. PubMed ID: 19500733 [Abstract] [Full Text] [Related]
8. Letter to the editor regarding "Definition of Barrett's esophagus: time for a rethink-is intestinal metaplasia dead?". DeMeester SR. Am J Gastroenterol; 2010 May 01; 105(5):1201-2; author reply 1202-3. PubMed ID: 20445513 [No Abstract] [Full Text] [Related]
9. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus. Rygiel AM, Milano F, Ten Kate FJ, Schaap A, Wang KK, Peppelenbosch MP, Bergman JJ, Krishnadath KK. Cancer Epidemiol Biomarkers Prev; 2008 Jun 01; 17(6):1380-5. PubMed ID: 18559552 [Abstract] [Full Text] [Related]
10. Correspondence re: R. Kim et al., Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Cancer Epidemiol., Biomark. Prev., 6: 369-377, 1997. Morgan G. Cancer Epidemiol Biomarkers Prev; 1998 Mar 01; 7(3):265. PubMed ID: 9521445 [No Abstract] [Full Text] [Related]
11. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus. Asthana N, Mandich D, Ligato S. Am J Surg Pathol; 2008 Oct 01; 32(10):1581-5. PubMed ID: 18724240 [Abstract] [Full Text] [Related]
13. The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus. Koss K, Harrison RF, Gregory J, Darnton SJ, Anderson MR, Jankowski JA. J Clin Pathol; 2004 Nov 01; 57(11):1156-9. PubMed ID: 15509675 [Abstract] [Full Text] [Related]
14. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study. Beales IL, Ogunwobi O, Cameron E, El-Amin K, Mutungi G, Wilkinson M. BMC Cancer; 2007 Jun 08; 7():97. PubMed ID: 17559672 [Abstract] [Full Text] [Related]
15. Chemoprotective effects of Curcuma aromatica on esophageal carcinogenesis. Li Y, Wo JM, Liu Q, Li X, Martin RC. Ann Surg Oncol; 2009 Feb 08; 16(2):515-23. PubMed ID: 19018598 [Abstract] [Full Text] [Related]
16. Editorial: One small step for metaplasia, but one giant leap for biomarkers is needed. Nicholson A, Jankowski J. Am J Gastroenterol; 2009 Nov 08; 104(11):2681-3. PubMed ID: 19888234 [Abstract] [Full Text] [Related]
17. Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus. Hermann B, Li Y, Ray MB, Wo JM, Martin RC. Arch Surg; 2005 Dec 08; 140(12):1204-9; discussion 1209. PubMed ID: 16365243 [Abstract] [Full Text] [Related]
18. Diagnosis and recognition of early esophageal neoplasia. Herszényi L, Pregun I, Tulassay Z. Dig Dis; 2009 Dec 08; 27(1):24-30. PubMed ID: 19439957 [Abstract] [Full Text] [Related]
19. Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation. Woodall CE, Li Y, Liu QH, Wo J, Martin RC. Anticancer Drugs; 2009 Jul 08; 20(6):437-43. PubMed ID: 19398904 [Abstract] [Full Text] [Related]
20. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence]. Mokrowiecka A, Wierzchniewska-Ławska A, Smolarz B, Romanowicz-Makowska H, Malecka-Panas E. Pol Merkur Lekarski; 2009 May 08; 26(155):385-9. PubMed ID: 19606680 [Abstract] [Full Text] [Related] Page: [Next] [New Search]